Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isoxazolidines as RIPK1 inhibitors and use thereof

Isoxazolidines as RIPK1 inhibitors and use thereof

US Patent 11897876 · Granted Feb 13, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders2025
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders2023
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders2021
Insulin conjugates2021
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2021
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2020
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2019
Fused tricyclic imidazo pyrazines as modulators of TNF activity2019
Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity,2019
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2019
Fused tricyclic imidazole derivatives as modulators of TNF activity2018
Fused tricyclic benzimidazoles derivatives as modulators of TNF activity2018